Diovan Hct
Product Images NDC 68258-6973

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diovan Hct (NDC 68258-6973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 68258-6972-03 (Ndc 68258 6972 03 Novartis)

Ndc 68258-6972-03 (Ndc 68258 6972 03 Novartis)
This is a description of a medication named DIOVAN HCT 160 mg/12.5 mg in the form of a dark red ovaloid tablet. Each tablet contains Valsartan USP 160 mg and Hydrochlorothiazide USP 12.5 mg. It comes in a package of 30 tablets with the NDC code 68258-6972-03 and product ID 6D0630. It is manufactured by Novartis Pharmaceuticals Corp. in Suffern, NY. The medicine may cause drowsiness, dizziness or headache and should be taken orally once daily as directed by a doctor. It is important to not discontinue the medication without a doctor's advice. It should also be kept out of children's reach and stored at 77° F.*
FDA Label Image

Ndc 68258-6973-03 (Ndc 68258 6973 03 Norvatis)

Ndc 68258-6973-03 (Ndc 68258 6973 03 Norvatis)
The text describes prescription medication for high blood pressure manufactured by Novartis Pharmaceuticals Corp. The medication is called Diovan HCT and contains two active ingredients: valsartan and hydrochlorothiazide. It comes in an orange/brown, oval-shaped tablet with the inscription "NVR/HXH." Each tablet contains 160mg of valsartan and 25mg of hydrochlorothiazide. The medicine should be taken orally once daily as directed by a doctor and stored in a tight/light-resistant container at 77°F. The text also mentions warnings about using the medication during pregnancy and the possible side effects. There are different batches of the medication with different lot numbers, and it is recommended to check the Rx# number for each batch. The text also mentions the manufacturer lot number, NDC code, and pedigree number. The medication should be dispensed only by authorized personnel, and it is for prescription use only. The text supplies the contact address and other information related to the medication's packaging.*
FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Diovan Hct 01)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Diovan Hct 01)
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Diovan Hct 02)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Diovan Hct 02)
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Diovan Hct 03)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Diovan Hct 03)
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Diovan Hct 04)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Diovan Hct 04)
FDA Label Image

Valsartan Structural Formula (Diovan Hct 05)

Valsartan Structural Formula (Diovan Hct 05)
FDA Label Image

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.